` ALZN (Alzamend Neuro Inc) vs S&P 500 Comparison - Alpha Spread

ALZN
vs
S&P 500

Over the past 12 months, ALZN has underperformed S&P 500, delivering a return of -80% compared to the S&P 500's +14% growth.

Stocks Performance
ALZN vs S&P 500

Loading
ALZN
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ALZN vs S&P 500

Performance Gap Between ALZN and GSPC
HIDDEN
Show

Performance By Year
ALZN vs S&P 500

Loading
ALZN
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Alzamend Neuro Inc vs Peers

S&P 500
ALZN
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Alzamend Neuro Inc
Glance View

Market Cap
8m USD
Industry
Biotechnology

Alzamend Neuro, Inc. is a preclinical stage biopharmaceutical company, which engages in the manufacture of pharmaceutical products. The company is headquartered in Tampa, Florida and currently employs 2 full-time employees. The company went IPO on 2021-06-15. The firm's pipeline consists of two therapeutic drug candidates: AL001 and AL002. The AL001 is a cocrystal technology delivering a therapeutic combination of lithium, proline and salicylate, known as AL001 or LiProSal, through two royalty-bearing worldwide licenses from the University of South Florida Research Foundation, Inc. (licensor). AL002 is a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer’s, known as AL002 or CA022W, through a royalty-bearing worldwide license from the licensor.

ALZN Intrinsic Value
HIDDEN
Show
Back to Top